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Response to comment by G. Borasi 
In his letter Prof. Borasi questions 1) whether an exponentially linear decrease of survival as 
a function of heating time has been proven for hyperthermia (HT) cell survival curves, or 
whether the linear quadratic (LQ) model [1] would be sufficient to describe such curves, and 
2) whether survival data should be weighted by the uncertainty of the data points prior to 
fitting.  
We are convinced that weighting clonogenic survival data by the relevant uncertainty in data 
points is the correct way of fitting. Each data point has its own uncertainty which may be 
seen as the ‘quality’ of that point. Knowing that there are differences in data quality, these 
should be accounted for during fitting. Weighting factors should be normalized to the 
relevant data point in order to account for differences in absolute values. Since our fit was 
based on a nonlinear least squares fit, weighting factors were also squared. This leads to an 
overall factor of std(S)2/mean(S)2 (S is the surviving fraction). Uncertainty weighting should 
not influence the overall shape of the fit if the model used describes the data well, and 
uncertainties lie within a normal range (i.e. there are no obvious outliers). Figure 1 below 
shows a comparison of weighted versus unweighted fitting to data from figure 1 of [2] fitted 
using the LQ-, and the AlphaR models. Here, we show that, for the data set used, the 
AlphaR model fit is more robust than that of the LQ-model. Although uncertainty weighting 
may influence the shape of the LQ fit, this is in its favour since points that are less accurately 
defined will draw the fit in a direction that does not reflect the underlying individual data 
points in their totality.   
In our article [2] we did not conclude that the HT survival data has an exponential asymptote, 
but presented a model that can describe such behaviour. This is an important difference. 
Whether the HT survival data allow us to discriminate clearly between a truly exponentially 
linear model for high thermal doses, or the LQ-model, cannot be answered with certainty. 
Naturally, models can only be falsified by data, but never be proven. In order to reject a 
model, such as the LQ-model, a threshold goodness of fit must be defined. Parameters, 
such as coefficients of determination, will only allow comparison with fits carried out under 
the same conditions, but it is difficult to decide at which numerical values a fit should be 
considered inadequate. The AlphaR model is capable of describing both linear quadratic and 
linear quadratic linear cell survival behaviours, and fits are therefore always equivalent to or 
superior to the LQ-model fits, while using the same number of free parameters for the HT 
curves (LQ: α and β, AlphaR: α0 and β). If a linear quadratic fit described the data better, the 
respective fit with the AlphaR model would be linear quadratic and the parameter α0 would 
be undeterminable.  
In our opinion, there are a number of arguments in favour of using the AlphaR model to fit 
HT survival curves: 1) Traditionally, HT cell survival data has been described using the 
Arrhenius model [3,4-6]. This assumes a purely exponentially linear decrease of survival as a 
function of heating time. The AlphaR model is able to describe such an exponentially linear 
asymptote. 2) In figure 1 below and our article we have demonstrated that a fit by the 
AlphaR model may be more robust and will be of equal to, or better quality than, a LQ-model 
fit. 3) An extrapolation of an AlphaR model fit beyond the range of experimental data used 
for fitting is possible. This is more difficult to achieve with the LQ-model fit.  An example for 
this is shown in figure 2 below. Here we use the methods described in [7] for radiotherapy 
application: The lowest survival data points were excluded from the fit, but considered for the 
calculation of the coefficients of determination. This provides some insight into how well the 
fit extrapolates beyond the fitted data range. The coefficients of determination obtained were 
R2LQ= 0.892, and R
2
AlphaR = 0.995 – which clearly favours the fit by the AlphaR model.  
Our study included twelve HT survival curves from three cell lines, reaching to surviving 
fractions as low as 10-5. We agree with Prof. Borasi that more experimental data at lower 
survival ranges would be useful for further validation and comparison of the models. 
However, such data may be very difficult, or even impossible, to obtain with current standard 
clonogenic assay techniques. Survival data in the range of 10-7 require the treatment and 
plating of a minimum of 108 cells per point, which is practically unachievable for a standard 
clonogenic assay. We are therefore sceptical as to whether more experimental data derived 
from clonogenic assays, e.g. from more cell lines, would provide evidence that would lead to 
a change in the conclusions drawn above.  
In summary, while we agree that there are limitations to the range of experimental data 
available, we feel that the proposed AlphaR model provides flexibility in modelling survival 
curves from different treatment modalities. It overcomes some of the limitations of the LQ-
model and that is why it was our model of choice for describing HT cell survival curves. 
These findings are independent of the underlying weighting of the data used for fitting. We 
will be happy to address this issue again when more extended high quality experimental 








Figure 1: Uncertainty weighted and unweighted fits using the AlphaR (left) and LQ-model (right) of HCT116 cell 
survival data at 48°C as a function of heating time. Whereas there is no big difference between the two fits for the 
AlphaR model fit, the curves of the LQ model show a more obvious influence of the weighting. The respective 
coefficients of determination are very similar: R
2
AlphaR Weighted= 0.997, R
2
AlphaR Unweighted = 0.996, R
2
LQ Weighted = 
0.991, R
2
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Figure 2: Uncertainty weighted fits using the AlphaR (left) and LQ-model (right) of HCT116 cell survival data at 
48°C as a function of heating time. The fit curves obtained with 95% confidence bounds (dashed lines) when 
fitting the data up to heating times of 5 min (round points) are shown. Fit curves were then extrapolated to longer 
heating times, and compared to additional experimental data (triangles) at 6 and 7 min. Whereas both models 
provide a good fit within the range of data included for fitting, the exponentially linear arm of the AlphaR model 
also provides a good fit in the extrapolated region (R
2
AlphaRAllData = 0.995), whereas the continuously bent LQ-
model would underestimate survival at higher heating times (R
2
LQAllData= 0.892).  
